Veracyte Other Stockholder Equity from 2010 to 2025

VCYT Stock  USD 31.10  0.05  0.16%   
Veracyte Other Stockholder Equity yearly trend continues to be comparatively stable with very little volatility. Other Stockholder Equity is likely to outpace its year average in 2025. From the period from 2010 to 2025, Veracyte Other Stockholder Equity quarterly data regression had mean square error of 68165.7 T and mean deviation of  596,519,441. View All Fundamentals
 
Other Stockholder Equity  
First Reported
2012-12-31
Previous Quarter
1.6 B
Current Value
1.2 B
Quarterly Volatility
558.2 M
 
Yuan Drop
 
Covid
Check Veracyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Veracyte's main balance sheet or income statement drivers, such as Depreciation And Amortization of 24.6 M, Interest Expense of 1.9 K or Selling General Administrative of 187.2 M, as well as many indicators such as Price To Sales Ratio of 13.72, Dividend Yield of 0.0 or PTB Ratio of 2.48. Veracyte financial statements analysis is a perfect complement when working with Veracyte Valuation or Volatility modules.
  
Check out the analysis of Veracyte Correlation against competitors.
For more information on how to buy Veracyte Stock please use our How to Invest in Veracyte guide.

Latest Veracyte's Other Stockholder Equity Growth Pattern

Below is the plot of the Other Stockholder Equity of Veracyte over the last few years. It is Veracyte's Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Veracyte's overall financial position and show how it may be relating to other accounts over time.
Other Stockholder Equity10 Years Trend
Slightly volatile
   Other Stockholder Equity   
       Timeline  

Veracyte Other Stockholder Equity Regression Statistics

Arithmetic Mean638,395,753
Coefficient Of Variation107.38
Mean Deviation596,519,441
Median325,806,000
Standard Deviation685,533,974
Sample Variance469956.8T
Range1.8B
R-Value0.93
Mean Square Error68165.7T
R-Squared0.86
Slope133,890,125
Total Sum of Squares7049352.4T

Veracyte Other Stockholder Equity History

20251.7 B
20241.7 B
20231.5 B
20221.5 B
20211.5 B
2020702.8 M
2019486.1 M

About Veracyte Financial Statements

Veracyte shareholders use historical fundamental indicators, such as Other Stockholder Equity, to determine how well the company is positioned to perform in the future. Although Veracyte investors may analyze each financial statement separately, they are all interrelated. The changes in Veracyte's assets and liabilities, for example, are also reflected in the revenues and expenses on on Veracyte's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Other Stockholder Equity1.7 B1.7 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Veracyte Stock Analysis

When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.